Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.

Observational Study to Evaluate the Safety and Efficacy of FURESTEM-AD Inj. in Moderate to Severe Atopic Dermatitis Patients Who Participated in Phase 1/2a Clinical Trial of FURESTEM-AD Lnj.

Observational Study to Assess the Safety and Efficacy of FURESTEM-AD lnj. In moderate to Atopic Dermatitis

This is a observational study, single center, open label, study of safety and Efficacy of FURESTEM-AD Inj. in subjects with moderate to severe Atopic Dermatitis.

Inclusion Criteria:

• Subjects participating in this observational study originally participated in study FURESTEM-RA Inj.[NCT02221258]
• Subject who understands and voluntarily sign an informed consent form

Exclusion Criteria:

• In case follow-up is not possible from end of clinical trial Phase 1/2a to end of this study period